With Pfizer’s vaccine being granted authorization in the UK and the prospect of a Covid-19 vaccine EUA here in the US, I wanted to take a moment to answer some of the most common questions surrounding these vaccines. (1/16)
“Why is it so tricky to distribute these vaccines?” It’s in large part because the two vaccines currently under EUA review have to be stored at super cold temperatures. (2/16)
Pfizer's vaccine needs the coldest storage at -70C; -94F and that is unavailable in most places. Pfizer has even designed special “thermal shippers” to help transport its vaccine. (3/16)
Moderna's vaccine requires storage at -20C; -4F. Also very cold, but doable in most hospitals. (4/16)
Other vaccines like the one from Astrazeneca/Oxford or Johnson & Johnson can be stored at 2-8C; 36-46F. Much easier because a simple refrigerator will do. (5/16)
Another common question: "Who gets it first?” Vaccine advisers to the CDC voted yesterday to recommend that both health care workers (21 million) and residents of long-term care facilities (3 million) be vaccinated first. (6/16) cnn.com/2020/12/01/hea…
“What about the rest of us?” Access to the vaccine will continue to be rolled out in phases. Yesterday Lt. Gen. Paul Ostrowski of OWS said by June, “A hundred percent of Americans who want the vaccine will have had the vaccine by that point in time.” (7/16)
“Could getting vaccinated result in getting an infection?” The answer is no and that’s because there is no actual virus in the vaccine, only the genetic code for a portion of the virus. (8/16)
The reason some people feel crummy after is because the vaccine is revving up the immune response. (9/16) cnn.com/2020/12/02/hea…
“Is it safe?” Both the Pfizer and Moderna vaccine needed to meet a two-month safety threshold before applying for an EUA, but long-term safety of the vaccines is still unknown. (10/16)
"I always make sure I say that while we know that the short-term – and I'm going to call it mid-term – safety of this vaccine is now well understood, the very long-term safety is not yet well understood by definition," Moncef Slaoui said Tuesday. (11/16) washingtonpost.com/washington-pos…
“Will I need to get the vaccine if I’ve already had Covid-19?” The answer: probably. (12/16)
The idea behind a vaccine is it should stage a stronger (and maybe longer) immune response than your body has after a natural infection. We still don’t know how long “natural immunity” from a Covid-19 infection might last. (13/16)
And finally, “Did Moderna really create a vaccine in just two days?” Yes and no. The mRNA platform Moderna uses for its vaccine was developed over many years. But the design for the Covid-19 vaccine was done just in two days. (14/16)
However, if this platform hadn’t already been developed, that two-day timeline would have been impossible. (15/16) cnn.com/videos/health/…
As we learn more about the vaccines, we’ll continue to answer your questions. In the meantime, stay safe and #BeKind . (16/16) cnn.com/video/data/2.0…
• • •
Missing some Tweet in this thread? You can try to
force a refresh
We’ve reached another sad milestone in this pandemic.
The US has surpassed a record of more than 60k Covid-19 hospitalizations for the 2nd consecutive day. (1/12)
But there is some glimmer of hope - a smaller percentage of people are dying now from Covid-19 than in the spring. (2/12) cnn.com/videos/health/…
One study of the @nyulangone health system found that in the spring, 25.6% of hospitalized Covid-19 patients wound up dying. By the summer, that rate had dropped by more than 2/3rds to 7.6%. (3/12) journalofhospitalmedicine.com/jhospmed/artic…
I want to take a moment to explain the big vaccine news today. #Pfizer is reporting early data showing their vaccine is “more than 90%” effective in preventing COVID-19. I spoke with #Pfizer’s CEO @AlbertBourla today, as the news broke early this morning (1/10)
Remember – this is an early read from a group of independent experts, not #Pfizer itself. Who are these experts? They’re known as the data safety monitoring board. (2/10) cnn.com/videos/health/…
What we know: out of nearly 44,000 trial participants, 94 were infected during the trial period. Here is the key finding: more than 90% of the infected cases occurred in the placebo group. Fewer than 10% of the infections occurred among those who had received the vaccine. (3/10)
DAY #4 President Trump hospitalization. There's still a number of unanswered questions about the president's health. Here's what Trump's doctors have told us so far. (1/20) cnn.com/2020/10/03/pol…
Dr. Sean Conley read a prepared statement Saturday morning saying Trump was diagnosed 72 hours ago, meaning Wednesday morning. Dr. Conley later changed the timeline to say the diagnosis was Thursday night. (2/20)
So, the timeline is still unclear, but we also don’t know the last time the president had a negative test. This is a critical detail. It allows the contact tracing of people he may have infected - and gives a clearer picture of where he is in his own disease course. (3/20)
After announcing a positive Covid-19 test early Friday morning, President Trump ended the day at Walter Reed National Military Medical Center, where we are told he’ll remain for “the next few days.” (1/12)
The White House said this was being done out of an “abundance of caution.” We know, however, that he developed progressive symptoms over the day, including a fever and fatigue. Mild symptoms can turn severe quickly, especially in a vulnerable individual. (2/12)
Take the case of Boris Johnson, UK’s Prime Minister. He was diagnosed with Covid-19 back in April. He also only reported mild symptoms at first, but more than a week later was hospitalized, including three nights in the ICU.(3/12)
Most people on the planet want a vaccine right now and we got some news this week that the process is speeding along. Getting a vaccine approved (or authorized) quickly will be critical, but how fast is too fast? Let’s take a look.(1/20) cnn.com/2020/09/13/hea…
Remember EUA - stands for Emergency Use Authorization - and permits the FDA to allow the use of unapproved drugs and products to manage a public health emergency. These terms are important. These products would be “authorized” but not yet “approved.”(2/20) fda.gov/emergency-prep…
For this pandemic - hundreds of EUAs have been issued for diagnostic tests but just two are currently being used for therapeutics - the antiviral remdesivir and convalescent plasma - donated antibodies from Covid-19 survivors. (3/20)
I spoke to FDA head @SteveFDA about the decision to issue an EUA (emergency use authorization) for convalescent plasma to treat those currently infected. While promising, it’s been controversial because many say the data is inadequate. (1/11) cnn.com/2020/08/23/hea…
Dr. Hahn told me “he should have better explained the data.” Here’s what he (incorrectly) said on Sunday night: Use of convalescent plasma reduced the risk of death by 35% and that meant if 100 people got coronavirus, 35 would survive. (2/11) whitehouse.gov/briefings-stat…
Last night he aimed to clarify that by telling me and then tweeting: “What I should have said better is that the data show a relative risk reduction not an absolute risk reduction.” This is a fundamental difference and important to understand. (3/11)